drugset / Trial / NCT03291067
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of MT-8554 for treatment of vasomotor symptoms (VMS) associated with menopause.
Timeline
- Start
- 2017-10-09
- Primary completion
- 2018-10-19
- Completion
- 2018-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elismetrep | Small molecule | 1 mg | Oral |
| Subject | Elismetrep | Small molecule | 5 mg | Oral |
| Subject | Elismetrep | Small molecule | 10 mg | Oral |